LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to:

Learning Objectives

1. Differentiate the pathophysiologic mechanisms and clinical presentations of invasive cardiomyopathies, including cardiac amyloidosis and cardiac sarcoidosis.

2. Identify key preoperative clinical, imaging, and hemodynamic findings that influence patient evaluation and treatment planning.

3. Evaluate patients with invasive cardiomyopathies for surgical intervention and mechanical circulatory support (MCS) using established clinical criteria.

4. Develop evidence-based postoperative management strategies for patients undergoing advanced therapies for invasive cardiomyopathies, including monitoring for complications and optimizing outcomes.

FACULTY DISCLOSURE: Ossama Abou Hassan, MD has a relevant financial relationship with Alnylam as a consultant.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Jarrod Cole at [email protected]